FDA Clearance Tracker · P220026-S014
Symplicity Spyral Renal Denervation System
Last checked: Nov 20, 2026Latest source record: Sep 10, 2026 (this decision)Source: openFDAMethods & limitations
Decided
Sep 10, 2026
Approved
Time to decision
225 days
Received Jan 28, 2026. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P220026-S014
- Device name
- Symplicity Spyral Renal Denervation System
- Applicant
- Medtronic, Inc.
- Applicant location
- Santa Rosa, CA
- Received
- Jan 28, 2026
- Decided
- Sep 10, 2026
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P220026
Device type
- Device type
- Ablation catheter, renal denervation (QYI)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
inclusion of data from post-approval studies in labeling
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
K262913 · Decided Sep 17, 2026 · 29 days after receipt
Device type: Stents, Drains And Dilators For The Biliary Ducts (FGE) · GI, Urology & Nephrology
K262735 · Decided Aug 28, 2026 · 28 days after receipt
Device type: Recorder, Event, Implantable Cardiac, (With Arrhythmia Detection) (MXD) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.